1. Home
  2. LOCO vs STRO Comparison

LOCO vs STRO Comparison

Compare LOCO & STRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo El Pollo Loco Holdings Inc.

LOCO

El Pollo Loco Holdings Inc.

HOLD

Current Price

$13.80

Market Cap

411.3M

ML Signal

HOLD

Logo Sutro Biopharma Inc.

STRO

Sutro Biopharma Inc.

HOLD

Current Price

$32.95

Market Cap

338.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LOCO
STRO
Founded
1980
2003
Country
United States
United States
Employees
N/A
131
Industry
Restaurants
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
411.3M
338.9M
IPO Year
2014
N/A

Fundamental Metrics

Financial Performance
Metric
LOCO
STRO
Price
$13.80
$32.95
Analyst Decision
Buy
Buy
Analyst Count
4
9
Target Price
$14.17
$28.00
AVG Volume (30 Days)
245.9K
204.2K
Earning Date
05-07-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
4.65
N/A
EPS
0.90
N/A
Revenue
$401,701,000.00
N/A
Revenue This Year
$3.60
N/A
Revenue Next Year
$3.98
N/A
P/E Ratio
$15.43
N/A
Revenue Growth
5.68
N/A
52 Week Low
$8.29
$0.67
52 Week High
$14.50
$36.00

Technical Indicators

Market Signals
Indicator
LOCO
STRO
Relative Strength Index (RSI) 54.89 66.85
Support Level $13.42 $0.78
Resistance Level $14.50 N/A
Average True Range (ATR) 0.31 2.40
MACD -0.11 0.53
Stochastic Oscillator 29.67 75.58

Price Performance

Historical Comparison
LOCO
STRO

About LOCO El Pollo Loco Holdings Inc.

El Pollo Loco Holdings Inc operates and franchises hundreds of fast-casual chicken restaurants in the United States. It specializes in fire-grilling citrus-marinated chicken and operates in the limited service restaurant market segment. Its offerings include Mexican-inspired menu items, including burritos, tostadas, bowls, salads, and bone-in chicken meals in various portion sizes. It also offers citrus-marinated fire-grilled chicken, along with a range of salsas and dressings that allow customers to customize their meals. The company operates in one operating segment. The majority of the company's revenue is derived from company-operated restaurant revenue.

About STRO Sutro Biopharma Inc.

Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.

Share on Social Networks: